GlassScriptPhysician profile
Donna White
NPI 1174958524
$699.77
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $549 · 2022: $150.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.57 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $117.20 | 2021 | |
| Antares Pharma, INC. | $62.07 | 2021 | |
| Acella Pharmaceuticals, LLC | $44.47 | 2022 | |
| Hologic Sales and Service, LLC | $35.30 | 2022 | |
| Allergan, INC. | $34.73 | 2021 | |
| Ibsa Pharma INC. | $31.51 | 2021 | |
| Lilly USA, LLC | $29.09 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.76 | 2022 | |
| Virtus Pharmaceuticals LLC | $24.01 | 2021 | |
| Therapeuticsmd, INC. | $18.68 | 2021 | |
| Daiichi Sankyo INC. | $17.38 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.